Lifeward(LFWD.US)

Company Encyclopedia

Lifeward

LFWD.US

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals’ post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd.

1.349 T

LFWD.USMarket value -Rank by Market Cap -/-

Financial Score

24/01/2026 Update

Health Care EquipmentIndustry

Industry Ranking102/176

Industry medianC

Industry averageC

Score Analysis

Peer Comparison

Criteria
Rating
Profit ScoreE
- ROE-127.95%E
- Profit Margin-121.82%E
- Gross Margin43.70%B
Growth ScoreD
- Revenue YoY-2.02%D
- Net Profit YoY-54.61%D
- Total Assets YoY-49.38%E
- Net Assets YoY-62.37%E
Cash ScoreD
- Cash Flow Margin-82.09%D
- OCF YoY-2.02%D
Operating ScoreB
- Turnover0.71B
Debt ScoreC
- Gearing Ratio44.95%C

Valuation analysis

P/E

10Y

P/E

Industry Ranking

-/-

P/E
Price
High
Median
Low

P/B

10Y

P/B

Industry Ranking

-/-

P/B
Price
High
Median
Low

P/S

10Y

P/S

Industry Ranking

-/-

P/S
Price
High
Median
Low

Dividend Yield

10Y

Dividend Yield

Industry Ranking

-/-

Dividend Yield
Price
High
Median
Low

Institutional View & Shareholder

Analyst Ratings

Rating

Percentage

Price
--
Highest
--
Lowest
--

Shareholder

Ownership	%Owned	Share Chg	Report Date
Citadel Advisors LLC	1.17%	No Change	30/09/2025
Renaissance Technologies LLC	0.72%	39.80 K	30/09/2025
Susquehanna International Group, LLP	0.64%	84.94 K	30/09/2025
The Lind Partners, LLC	0.52%	No Change	31/03/2025
Cambridge Investment Research Advisors, Inc.	0.46%	7.19 K	30/09/2025
Michael J. Swinford	0.4%	8.97 K	27/11/2025
Joseph E. Turk	0.28%	17.95 K	27/11/2025
Two Sigma Securities, LLC	0.25%	No Change	30/09/2025
XTX Markets Limited	0.22%	No Change	30/09/2025
Jane Street Group, LLC	0.21%	No Change	30/09/2025

News

How far have domestic surgical robots come?

The domestic surgical robot industry is at a critical turning point from "concept validation" to "scale profitability." Zheshang Securities predicts that the market size of surgical robots in China will reach 7.2 billion yuan in 2024 and will surge to 76.7 billion yuan by 2032, with a compound annual growth rate of approximately 34%. Policy support and the expansion of overseas markets will drive rapid growth in the industry, with laparoscopic surgical robots accounting for 58% of the market. The orthopedic surgical robot market is also developing rapidly, with an expected compound annual growth rate of 41% from 2024 to 2032

Wallstreetcn·Yesterday at 17:05

Wallstreetcn·Yesterday at 17:05

10:58 ET Global Optical Coherence Tomography (OCT) Market Projected To Reach USD 4.2 Billion by 2035 - Future Market Insights (FMI)

The global optical coherence tomography (OCT) market is projected to grow from USD 1.6 billion in 2025 to USD 4.2 billion by 2035, with a CAGR of 11.1%. The growth is driven by increasing chronic diseases, advancements in AI imaging, and the expansion of non-ocular applications. Ophthalmology will remain the largest segment, accounting for 69.2% of the market in 2025. North America leads the market share, while Asia-Pacific is the fastest-growing region. Regulatory scrutiny is increasing, and innovation in AI and portable systems presents significant growth opportunities.

prnewswire·01/23/2026 00:00

Global OCT market to reach $4.2B by 2035, growing at 11.1% CAGR from $1.6B in 2025. Structural transition drives growth.

In Newark, Delaware, on January 22, 2026, it was reported that the worldwide optical coherence tomography (OCT) market is projected to grow at a CAGR of 11.1%. Starting at USD 1.6 billion in 2025, it is expected to reach USD 4.2 billion by 2035. This significant growth signifies a structural shift within the market.

Unusual Whales·01/22/2026 23:59

Lifecare ASA Raises NOK 80 Million in Rights Issue with Warrant Allocation

Lifecare ASA has announced a rights issue, raising NOK 80 million by offering approximately 160 million new shares at NOK 0.50 each. The company received subscriptions for about 142.8 million shares, which includes around 214 million warrants. Subscribers will receive three warrants for every four shares allocated, to be exercised in March and June 2026. Final results will be published after the process concludes.

Reuters·01/22/2026 03:19

Reuters·01/22/2026 03:19

Global computer vision in healthcare market to grow by $10.97 billion by 2030 with a CAGR of 31.1%. Report covers market trends and vendor analysis.

A recent market report on Computer Vision in Healthcare forecasts significant growth, with the global market expected to increase by USD 10.97 billion from 2025 to 2030. The market is projected to experience a remarkable Compound Annual Growth Rate (CAGR) of 31.1% during this period. The report offers a thorough analysis of the market, encompassing size, future projections, trends, factors driving growth, challenges, and an extensive vendor analysis of around 25 key players.

Unusual Whales·01/22/2026 02:51